Orient Pharma Co. Ltd. (4166 TWO) stock market data APIs
NT$24.2425
-0.33(-1.4%)
as of March 20, 2026
Try our APIs with
free plan!
Orient Pharma Co. Ltd. Financial Data Overview
Price chart is built with
Anychart
Orient Pharma Co., Ltd. engages in the development of new drugs in Taiwan and internationally. It offers cardiovascular drugs, such as Pitator and Tonvasca for lipid suppression, as well as Zulitor, a lipid lowering drug; psychotropic drugs, including Trokendi XR extended, Methydur, and powder and solvent for prolonged-release suspension for injection. The company was founded in 2008 and is based in Taipei, Taiwan.
Prev. Close
24.2425
Open
23.908
High
24.7162
Low
23.6048
52 wk Range
22.3-40
Market Cap
5 857 M
P/E Ratio
26.7778
Shares Outstanding
243 M
Revenue
1 400 M
Beta
0.105
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Orient Pharma Co. Ltd. data using free add-ons & libraries
Get Orient Pharma Co. Ltd. Fundamental Data
Orient Pharma Co. Ltd. Fundamental data includes:
- Net Revenue: 1 400 M
- EBITDA: 397 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Orient Pharma Co. Ltd. News
New
Undiscovered Gems in Global Markets for November 2025
In the current global market landscape, investor sentiment is heavily influenced by concerns over AI-related valuations and the potential for further interest rate cuts. Despite these challenges, smal...
Undiscovered Gems in Asia Three Promising Stocks for July 2025
As global markets continue to navigate a complex landscape, Asian markets have shown resilience with modest gains in key indices like Japan's Nikkei 225 and China's CSI 300. Amidst this backdrop, iden...
Get Orient Pharma Co. Ltd. fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
